NRG Therapeutics

energizing drug discovery in neurodegenerative diseases

NRG Therapeutics is headquartered in Stevenage, United Kingdom, lists 11–50 employees, and has $87.3M in recorded funding across 2 rounds.

Headquarters
Stevenage
Employees
11–50
Business Model
B2B
Total Funding
$87.3M
Last Round
$67.0M Series BSep 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

NRG Therapeutics is leveraging breakthrough science in mitochondrial biology and disease mechanisms to develop novel medicines to treat neurodegenerative disorders. The company's pipeline of first-in-class, CNS-penetrant, oral small molecules is based on inhibiting the mitochondrial permeability transition pore (mPTP) through a novel mechanism of action. Its lead drug candidate NRG5051 commenced a first-in-human clinical trial in 2026.

Summary

NRG Therapeutics is a Biotech company based in Stevenage, United Kingdom. It lists 11–50 employees. It has raised $87.3M in total across 2 rounds, most recently a $67.0M Series B round in Sep 2025. Investors include M Ventures, SV Health Investors and Omega Funds.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025
$67.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NRG Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nrg-therapeutics"><img src="https://indexed.vc/api/badge/company/nrg-therapeutics" alt="NRG Therapeutics on Indexed.vc" width="260" height="76" /></a>